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Background: Prehabilitation has emerged as a strategy to prepare patients for elective abdominal cancer
surgery with documented improvements in postoperative outcomes. The aim of this study was to assess
the evidence for prehabilitation interventions of relevance to the older adult.
Methods: Systematic searches were conducted using MEDLINE, Web of Science, Scopus, CINAHL
and PsychINFO. Studies of preoperative intervention (prehabilitation) in patients undergoing abdominal
cancer surgery reporting postoperative outcomes were included. Age limits were not set as preliminary
searches revealed this would be too restrictive. Articles were screened and selected based on PRISMA
guidelines, and assessment of bias was performed. Qualitative, quantitative and meta-analyses of data
were conducted as appropriate.
Results: Thirty-three studies (3962 patients) were included. Interventions included exercise, nutrition,
psychological input, comprehensive geriatric assessment and optimization, smoking cessation and multi-
modal (two or more interventions). Nine studies purposely selected high-risk, frail or older patients.
Thirty studies were at moderate or high risk of bias. Ten studies individually reported benefits in
complication rates, with meta-analyses for overall complications demonstrating significant benefit:
multimodal (risk difference−0⋅1 (95 per cent c.i. −0⋅18 to −0⋅02); P = 0⋅01, I2 = 18 per cent) and
nutrition (risk difference−0⋅18 (−0⋅26 to −0⋅10); P<0⋅001, I2 = 0 per cent). Seven studies reported
reductions in length of hospital stay, with no differences on meta-analysis.
Conclusion: The conclusions of this review are limited by the quality of the included studies, and the
heterogeneity of interventions and outcome measures reported. Exercise, nutritional and multimodal
prehabilitation may reduce morbidity after abdominal surgery, but data specific to older patients are
sparse.
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Introduction
The majority of cancers in the UK are diagnosed in the
older adult population (aged 65 years and above), with
this population predicted to increase exponentially1. The
pathogenesis and treatment of cancer can lead to a decline
in cardiorespiratory fitness, weight loss and psychologi-
cal morbidity2. Surgery remains the mainstay of curative
treatment for many gastrointestinal, gynaecological and
urological cancers, but outcomes are poorer in the older
adult, making strategies to optimize this complex group
increasingly important.
Adverse factors associated with ageing include
co-morbidity, polypharmacy, cognitive impairment,
dependency and frailty, all of which are associated with
increased all-cause mortality in the general population3.
When these at-risk individuals are exposed to the stress of
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Fig. 1 Summary of prehabilitation intervention components and exclusions
Exercise
Aerobic – high/medium
 intensity
Resistance and
 strengthening
Stretching
Inspiratory muscle training
Pulmonary physiotherapy
Excluding
Intensive inpatient
 rehabilitation only
Nutrition
Oral nutritional
 supplements for 7 days
 or more (ESPEN
 guidelines)
With or without nutritional
 assessment and dietary
 counselling
Excluding
Inpatient nasogastric or
 total parenteral nutrition
Immunonutrition
Carbohydrate loading
Psychological
Tailored information
Education
Surgery school
Coping strategies
Audio recordings
Psychotherapy
Enhanced support
Smoking cessation
Counselling
Nicotine replacement
 therapy
Multimodal
Exercise + Nutrition ± Psychological ± Smoking cessation ± Haematinic optimization
Excluding Enhanced protocols alone
CGA and optimization
CGA ± Medication review ± Nutrition ± Psychological ± Delirium prevention
± Functional optimization ± Shared decision-making ± Smoking cessation
± Haematinic optimization
Excluding CGA only (no optimization)
ESPEN, European Society for Clinical Nutrition and Metabolism; CGA, comprehensive geriatric assessment.
major cancer surgery, postoperative mortality and morbid-
ity also increase4,5. Common lifestyle choices, including
smoking, poor nutrition and sedentary behaviours, add
to this risk. ‘Prehabilitation’, the process of enhanc-
ing an individual’s functional capacity before elective
surgery with the aim of improving tolerance to the antic-
ipated physiological stress of major surgery, may have
a role in improving postoperative outcomes6. Prehabil-
itation programmes vary in their components, but can
include exercise programmes, nutritional or psychological
interventions7. Where they encompass different types of
intervention, they are referred to as ‘multimodal’8. In the
context of the older adult, programmes may also include
preoperative comprehensive geriatric assessment (CGA)
and optimization. A summary of intervention types is
presented in Fig. 1.
Early prehabilitation studies focused on the safety and
feasibility of unimodality interventions9. More recently,
studies have been more likely to be multimodal and to
involve higher-risk populations10. Previous systematic
reviews11–20 focused predominantly on single-modality
prehabilitation in mixed surgical populations. This review
addresses the need for an updated review of the entire
spectrum of prehabilitation interventions in elective
abdominal cancer surgery with particular relevance to the
older patient.
Methods
This systematic review and meta-analysis was conducted
with reference to the Cochrane Handbook and is reported
using the PRISMA guidelines21. The protocol was regis-
tered with PROSPERO (CRD42019120381). The primary
objective was to determine whether any modality of preha-
bilitation (alone or in combination) before elective abdom-
inal surgery leads to a reduction in either length of hospital
stay (LOS) or complications (overall, pulmonary, wound
infection rate, delirium, severe complications) compared
with a control arm that does not include prehabilitation.
The review was undertaken with particular relevance to
older adults. Secondary objectives were to determine any
effect on functional outcome measures (physical activity or
walking capacity, weight loss, discharge independence) and
psychological outcome measures (quality of life (QoL)).
Search strategy
Systematic searches were performed of the MEDLINE,
Web of Science, Scopus, Cumulative Index to Nursing and
Allied Health Literature (CINAHL), PsychINFO and the
Cochrane databases for papers published from database
inception to January 2019. Preliminary searches revealed
that limiting the searches to studies performed in older
adults would be too restrictive and result in the exclusion
of potentially relevant studies; therefore no age limits were
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Fig. 2 PRISMA diagram for the review
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Additional records identified
through other sources
n = 47
Records excluded n = 238
Full-text articles excluded n = 97
 Availability of manuscript n = 13
 Study design n = 1
 Intervention n = 30
 Reanalysis of earlier trial n = 8
 Population n = 29
 Language n = 5
 Outcomes not reported n = 11
Records after duplicates removed
n = 2591
Records screened
n = 368
Full-text articles assessed
for eligibility
n = 130
Studies included in
qualitative synthesis
n = 33
Studies included in
quantitative synthesis
(meta-analysis)
n = 19
set. Searches were limited to studies published in the
English language as resources were not available to support
translation. The search was constructed using the PICO
(patient, intervention, comparison, outcome) framework:
Patient (adults undergoing abdominal or gastrointesti-
nal surgery); Intervention (prehabilitation or preoperative
optimization); Comparator (standard care or rehabilitation
only); and Outcome (primary: LOS or complication rates).
Clinical.Trials.gov was also searched for trials that had been
completed but not published. A sample search strategy is
shown in Appendix S1 (supporting information).
Inclusion and exclusion criteria
Randomized, case–control, cohort or retrospective studies
reporting on adults (aged 18 years or above) undergoing
surgery with curative intent for any gastrointestinal
(oesophagus, stomach, pancreas, liver, colorectal) or
intra-abdominal (urological or gynaecological) can-
cer were included. Studies including mixed surgical
populations were included if they reported the cancer and
non-cancer results separately or if more than 50 per cent
of the population were patients with cancer. Studies could
test any prehabilitation intervention or preoperative opti-
mization strategy, alone or in combination (multimodal),
and had to report outcomes in a control group. Control
groups could include standard care, placebo, postoperative
rehabilitation programme only, information leaflet or ver-
bal advice on preparing for surgery and positive behaviour
change (for example smoking cessation or alcohol reduc-
tion) in line with current perioperative care guidelines.
Studies of postoperative interventions only were excluded,
as were studies that did not report on either of the primary
outcomes. Studies published only in abstract form without
full text were excluded. Reference lists of primary studies
and relevant systematic reviews were also hand-searched
for additional studies.
Screening of all titles and abstracts was undertaken inde-
pendently by two reviewers. Articles were considered for
© 2020 The Authors. www.bjsopen.com BJS Open
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Table 1 Cochrane risk-of-bias tool results for randomized studies
Reference
Randomization
(selection
bias)
Allocation
concealment
(selection
bias)
Blinding
of participants
and personnel
(performance
bias)
Blinding
of outcome
assessment
(detection
bias)
Incomplete
outcome
data
(attrition
bias)
Selective
reporting
(reporting
bias)
Other
sources
of bias
(other bias)
Exercise alone
Banerjee et al.25 + + − + + ? ?
Barberan-Garcia et al.10 + + + + + + ?
Boden et al.36 + + + + + ? ?
Carli et al.9 + ? − ? + ? ?
Dronkers et al.42 + ? − + + ? ?
Dunne et al.43 + + − + + ? ?
Santa Mina et al.44 ? ? − ? + + ?
Soares et al.45 ? ? − − + + ?
Yamana et al.46 ? ? − − + ? ?
Multimodal
Bousquet-Dion et al.47 + + − − + ? ?
Gillis et al.26 + + − + + ? ?
Jensen et al.27 + + − − ? + ?
Kaibori et al.28 ? ? − ? + ? ?
Minnella et al.29 + + − + + + ?
Nutrition
Burden et al.40 + + − + + + ?
Gillis et al.30 + + + + + ? ?
Kabata et al.31 + + − ? + ? ?
Kong et al.41 + ? − − + ? ?
MacFie et al.32 ? ? − ? + ? ?
Smedley et al.33 ? ? − ? + ? ?
Psychological
Chaudhri et al.34 ? ? − + ? ? ?
Haase et al.35 ? ? − + + ? ?
CGA and optimization
Hempenius et al.37 + + − ? + ? ?
Ommundsen et al.38 + + − + + ? ?
Smoking
Sørensen and Jørgensen39 + + − + + ? ?
+, Low risk of bias; −, high risk of bias; ?, unclear risk of bias. CGA, comprehensive geriatric assessment.
full-text review if they met the study inclusion criteria or
could not be excluded on the basis of the abstract alone.
Full-text articles were retrieved and assessed by the same
two reviewers. Disagreements were addressed by discus-
sion and consensus and, if required the opinion of a third
reviewer was sought.
Definitions of eligible interventions
Eligible interventions included exercise interventions
(either alone or in combination with pulmonary exercises),
nutritional assessment and supplementation, psychological
interventions, CGA and optimization, smoking cessation
and multimodal (two or more modalities). These are
summarized in Fig. 1.
Assessment of study quality
Risk-of-bias assessment was performed using the Cochrane
risk-of-bias tool22 for randomized trials and the Risk
of Bias In Non-randomized Studies – of Interventions
(ROBINS-I) 23 for non-randomized trials. Randomized
studies were graded for risk of bias (+, low risk; −, high
risk; ?, unclear risk) in each of the following domains:
sequence generation, allocation concealment, blinding,
incomplete outcome data, selective outcome reporting
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Table 2 ROBINS-I tool results for non-randomized studies
Reference Type of study
Bias due to
confounding
Bias in
selection of
participants
Bias in
classification
of interventions
Bias due to
deviations
from intended
interventions
Bias due
to missing
data
Bias in
measurement
of outcomes
Bias in
selection
of reported
result
Multimodal
Chia et al.48 Prospective,
before and after
intervention
Moderate High Low Low Low Moderate Low
Li et al.49 Prospective,
before and after
intervention
Moderate Low Low Low Low Moderate Low
Mazzola et al.50 Prospective
cohort,
retrospective
control
Moderate Low Low Low Low Moderate Low
Nakajima et al.51 Prospective
cohort,
retrospective
control
Moderate Moderate Low Low Low Moderate Low
Souwer et al.52 Prospective,
before and after
intervention
Moderate Low Low Low Low Moderate Low
Nutrition
Manˇásek et al.53 Prospective
cohort,
retrospective
control
Moderate Moderate Low Low Low Moderate Low
CGA and optimization
Indrakusuma et al.55 Retrospective
cohort
Moderate Moderate Moderate Low Low Moderate Low
McDonald et al.54 Case–control
(matched)
Moderate Low Low Low Low Moderate Low
CGA, comprehensive geriatric assessment.
and other source of bias. Non-randomized studies were
assessed on bias due to confounding, selection, classifica-
tion of interventions, deviations from intended interven-
tions, missing data, outcome measurement and reporting.
Quality assessment was undertaken independently by two
reviewers, and disagreements were resolved by consensus.
Data extraction
Data were extracted according to a predesigned pro forma,
which included study characteristics, baseline data, inter-
vention characteristics, adherence and outcomes. Studies
were divided according to modality: exercise (alone or
including pulmonary training), multimodal, nutrition, psy-
chological, smoking, and CGA with optimization.
The primary outcomes, LOS and complication rates,
were recorded as mean(s.d.) values and proportions respec-
tively.Where themeanwas not reported, an approximation
was calculated from the median and range22. Complica-
tion rates were recorded as total, severe (Clavien–Dindo
grade III or above) or pulmonary complications, wound
infections and delirium within 30 days of surgery. Sec-
ondary outcomes were extracted where reported: change
in functional outcome measures (preoperative change in
6-minute walk test (6MWT) or cardiopulmonary exercise
test (CPET) variables of physiological fitness, percent-
age preoperative weight loss or discharge independence),
or psychological outcomes (postoperative Hospital Anxi-
ety and Depression Scale (HADS), Short Form 36 Health
Survey (SF-36®; Rand Corporation, Santa Monica, Cali-
fornia, USA) or European Organisation for Research and
Treatment of Cancer Quality of Life Questionnaire Core
29 and 30 (EORTC QLQ-C29/C30) score).
Statistical analysis
Qualitative analyses were performed for all studies that
met the inclusion criteria. Studies were analysed according
to the type of prehabilitation intervention. Meta-analysis
was performed using RevMan software (Review Man-
ager version 5.3, 2014; The Cochrane Collaboration,
The Nordic Cochrane Centre, Copenhagen, Denmark)
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Table 3 Summary of outcomes and results for exercise prehabilitation
Reference Adherence (%) Primary study outcome Postoperative outcomes* Functional outcomes* Psychological outcomes*
Banerjee et al.25 92 Feasibility All complications: 4 of 30
versus 10 of 30, P = 0⋅075
CDC grade≥ III: 1 of 30 versus
4 of 30
Pneumonia: 3 of 30 versus 2 of
30
LOS: median 7 (4–78) versus 7
(5–107) days
Peak OP: +1⋅36 (95% c.i.
0⋅63, 2⋅10) ml/beat,
P = 0⋅001
Peak VE: +7⋅49 (95% c.i.
2⋅86, 12⋅12) l/min.
P = 0⋅02
Peak power output: +19
(95% c.i. 10, 27) W.
P<0⋅001
Barberan-Garcia et al.10 87 Any complications All complications: 20 of 62
versus 38 of 63, P = 0⋅001;
RR 0⋅5 (95% c.i. 0⋅3, 0⋅8)
Pulmonary: 4 of 63 versus 10
of 62, P = 0⋅155
Wound: 1 of 63 versus 1 of 62
LOS: mean(s.d.): 8(8) versus
13(20) days, P = 0⋅078
6MWT: no difference SF-36®: PCS n.s.
HADS anxiety and
depression: no change
in either group
Boden et al.36 98 Pulmonary complications
within 14days
Any complication within
6weeks: 74 of 192 versus 79
of 197
Pulmonary: 27 of 218 versus 58
of 214 (adjusted HR 0⋅48,
95% c.i. 0⋅30, 0⋅75,
P = 0⋅001)
Wound: 36 of 192 versus 40 of
197
LOS: median 8 (6–11) versus 9
(7–13) days
Carli et al.9 79 Change in 6MWT before
and after surgery
All complications: 22 of 56
versus 18 of 54
CDC grade≥ III: 6 of 56 versus
3 of 54
LOS: mean(s.e.) 11⋅9(34⋅6)
versus 6⋅6(3⋅6) days
6MWT: baseline to preop.
−10⋅6(7⋅3)
versus+ 8⋅7(6⋅8)
Mean peak VO2: +134
versus+ 112ml/min
HADS anxiety: baseline to
postop. follow-up
−1⋅8(0⋅7)
versus−2⋅0(0⋅5), P n.s.
HADS depression:
−0⋅8(0⋅6)
versus−0⋅4(0⋅5), P n.s.
Dronkers et al.42 97 Feasibility All complications: 9 of 22
versus 8 of 20
Pulmonary: 5 of 22 versus 5 of
20
LOS: mean(s.d.) 16⋅2(11⋅5)
versus 21⋅6 (23⋅7) days
EORTC QLQ-C30: P n.s.
Dunne et al.43 92 Oxygen uptake at AT All complications: 8 of 19
versus 7 of 15
CDC grade≥ III: 3 of 19 versus
1 of 15
Pneumonia: 2 of 20 versus 3 of
17
Wound: 3 of 20 versus 0 of 17
LOS: median (range) 5 (4–6)
versus 5 (4⋅5–7) days
VO2 at AT: +1⋅5 (95% c.i.
0⋅2, 2⋅9) ml per kg per
min, P = 0⋅023
Peak work rate: +13 (95%
c.i. 4, 22) W, P = 0⋅005
SF-36 ® overall QoL
score: +11 (95% c.i. 1,
21), P = 0⋅028
SF-36 ® overall mental
health score: +11 (1,
22), P = 0⋅037
Santa Mina et al.44 69 Feasibility All complications: 18 of 44
versus 14 of 42
CDC grade≥ III: 1 of 44 versus
1 of 42
LOS: mean(s.d.) 1⋅7(0⋅9) versus
1⋅76(1⋅0)
6MWT preop.:
+14⋅6(+14⋅5) (95% c.i.
−13⋅87, 43⋅05),
P = 0⋅313
HADS anxiety postop.:
difference estimate
+0⋅47(0⋅68), P = 0⋅49
Soares et al.45 Pulmonary function
change and 6MWT
Pulmonary: 5 of 16 versus 11
of 16, P = 0⋅03
LOS: median (range) 8⋅5
(4⋅8–12⋅3) versus 8⋅5
(6⋅5–17⋅3) days
6MWT preop: 514⋅4
(460–557⋅5) versus
441⋅5 (412⋅3–505⋅9),
P = 0⋅105
Yamana et al.46 100 Pulmonary complications Pulmonary (CDC grade≥ III): 3
of 30 versus 5 of 30,
P = 0⋅014
*Comparative data show intervention and control results respectively. CDC, Clavien–Dindo classification; LOS, length of hospital stay; OP, oxygen pulse; VE, minute ventilation;
RR, relative risk; 6MWT, 6-minute walk test; SF-36®, Short Form 36; PCS, physical component score; HADS, Hospital Anxiety and Depression Scale; HR, hazard ratio; VO2,
oxygen consumption; n.s., not significant; EORTC QLQ, European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire; AT, anaerobic threshold;
QoL, quality of life.
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Fig. 3 Forest plots showing the effect of exercise prehabilitation on overall and pulmonary complications, and length of hospital stay
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aOverall complications; b pulmonary complications; cmean(s.d.) length of hospital stay (LOS). a,bMantel–Haenszel random-effects models were used for
meta-analysis; risk differences are shown with 95 per cent confidence intervals. c An inverse-variance model was used for meta-analysis; mean differences
are shown with 95 per cent confidence intervals.
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Table 4 Summary of outcomes and results for multimodal prehabilitation
Reference Adherence (%)
Primary study
outcome Postoperative outcomes* Functional outcomes* Psychological outcomes*
Bousquet-Dion et al.47 98 Exercise capacity
6MWT
All complications: 14 of 37 versus 8
of 26
Wound: 5 of 37 versus 3 of 26
CDC grade≥ II: 5 of 37 versus 4 of
26
CDC grade≥ III: 2 of 41 versus 0 of
39
LOS: median (i.q.r.) 3 (3–4) versus 3
(2–4) days, P = 0⋅122
6MWT: mean(s.d.)
difference+21(47)
versus+10(30) m, P n.s.
HADS anxiety
score>7: 35%
versus 23%
HADS depression
score>7: 11%
versus 19%
Chia et al.48 LOS,
complications
Complications (CDC grade≥ III): 3
of 57 versus 5 of 60, P = 0⋅511
LOS: 8⋅4 versus 11days, P = 0⋅029
Gillis et al.26 78 6MWT at 8weeks All complications: 12 of 38 versus
17 of 39, P = 0⋅277
Wound: 3 of 38 versus 3 of 39
CDC grade≥ III: 4 of 38 versus 6 of
39
Pulmonary: 1 of 38 versus 0 of 39
LOS: 4 (i.q.r. 3–5) versus 4
(3–7) days, P = 0⋅812
6MWT preop.: mean(s.d.)
+25⋅2(50⋅2)
versus−16⋅4(46) m; mean
difference 41⋅7 (95% c.i.
19⋅8, 63⋅6) m; adjusted
P<0⋅001
SF-36®/HADS: P n.s.
Jensen et al.27 59 Feasibility All complications: 30 of 50 versus
34 of 57
LOS: median 8 (3–30) versus 8
(4–55), P = 0⋅68
Kaibori et al.28 Whole body mass
and fat mass
All complications: 2 of 23 versus 3
of 23, P = 0⋅671
LOS: mean(s.d.) 13⋅7(4⋅0) versus
17⋅5(11⋅3), P = 0⋅12
Li et al.49 70 (partial) 6MWT at 8weeks All complications: 15 of 42 versus
20 of 45
CDC grade≥ III: 2 of 42 versus 1 of
45
LOS: median (i.q.r.) 4 (3–6) versus 4
(3–6) days
6MWT preop.: 464(92) versus
402(57) m baseline
(prehabilitation group only),
P<0⋅01
SF-36®: P n.s.
Mazzola et al.50 Mortality,
complications
All complications: 17 of 41 versus
26 of 35, P = 0⋅005
CDC grade≥ III: 7 of 41 versus 15
of 35, P = 0⋅02
Pulmonary: 2 of 41 versus 1 of 35
LOS: median (range) 17 (7–76)
versus 27 (8–146) days, P = 0⋅08
Minnella et al.29 63 6MWT before and
after surgery
All complications: 14 of 24 versus
18 of 25
CDC grade≥ II: 12 of 24 versus 16
of 25
CDC grade≥ III: 6 of 24 versus 10
of 25
LOS: median (i.q.r.) 8 (5⋅75–11⋅75)
versus 7 (5⋅5–12⋅5) days,
P = 0⋅44
6MWT preop.: mean(s.d.)
change +36⋅9(51⋅4)
versus−22⋅8(52⋅5) m,
P<0⋅001
Nakajima et al.51 Preop. nutritional
status and
postop. course
Complications (CDC grade≥ III): 32
of 76 versus 38 of 76
Pneumonia: 1 of 76 versus 1 of 76
Wound: 2 of 76 versus 3 of 76
LOS: median (i.q.r.) 23 (16–34)
versus 30 (21–40) days,
P = 0⋅045
Prehabilitation (no control)
6MWT: median (i.q.r.)
baseline 530 (470–571) to
preop. 554 (499–620) m,
P<0⋅001
Souwer et al.52 1-year mortality All complications: 24 of 86 versus
26 of 63
CDC grade≥ III: 14 of 86 versus 24
of 75 (OR 0⋅4 (95% c.i. 0⋅2, 0⋅9),
P = 0⋅03)
Pulmonary: P = 0⋅3
LOS ≥14days: 5 of 86 versus 17 of
63days (OR 0⋅2 (0⋅1, 0⋅5),
P = 0⋅001
*Comparative data show intervention and control results respectively. 6MWT, 6-minute walk test; CDC, Clavien–Dindo classification; LOS, length of hospital stay; n.s., not
significant; HADS; Hospital Anxiety and Depression Scale; SF-36®, Short Form 36; OR, odds ratio.
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Fig. 4 Forest plots showing the effect of multimodal prehabilitation on overall complications and length of hospital stay
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where the number (greater than 3) and quality of studies
permitted, if the 95 per cent c.i. overlapped and effect
sizes were similar24. Meta-analysis was performed using
random-effects models, assessing risk difference for both
dichotomous and continuous outcomes. Heterogeneity
was assessed using the I2 statistic. Significance was set at
α = 0⋅050.
Results
Searches were performed on 6 January 2019. Some
130 papers were identified for full text review; 97
were excluded, leaving 33 studies for inclusion (Fig. 2).
There were 25 RCTs (including pilot and feasibility
studies)9,10,25–47, seven prospective cohort studies (with
either contemporary or historical controls)48–54, and
one retrospective study55. Three studies32,33,35 reported
two separate intervention groups, resulting in a total of
36 interventions for comparison (Table S1, supporting
information).
Baseline characteristics
The studies, published between 2000 and 2019, included
2028 patients undergoing prehabilitation and 1934
controls. Interventions comprised: exercise only (9
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Table 5 Summary of outcomes and results for nutrition prehabilitation
Reference
Adherence
(%)
Primary study
outcome Postoperative outcomes* Functional outcomes*
Psychological
outcomes*
Burden et al.40 75
(estimated)
SSI or chest
infection
All complications: 23 of 54 versus 35
of 62, P = 0⋅114
Pneumonia: 5 of 54 versus 4 of 62
CDC grade≥ III: 9 of 54 versus 10 of
62
SSI: 11 of 55 versus 17 of 45 (OR 0⋅41
(95% c.i. 0⋅16, 1⋅00), P = 0⋅044)
LOS: median (i.q.r.) 7 (4–10⋅5) versus
7 (4–10) days, P = 0⋅63
% weight loss preop.:
median (i.q.r.) 4⋅1
(1⋅7–7⋅0) versus 6⋅7
(2⋅6–10⋅8), P = 0⋅016
Gillis et al.30 93⋅7–96⋅6 6MWT before
and after
surgery
All complications: 8 of 22 versus 9 of
21
CDC grade≥ III: 2 of 22 versus 2 of 21
Pneumonia: 0 of 22 versus 1 of 21
LOS: median 5 (3–13) versus 4
(3–10) days
6MWT: mean(s.d.)
+20⋅8(42⋅6)
versus+1⋅2(65⋅5) m,
P = 0⋅27
SF-36 ® postop.:
PCS 41⋅3
(34⋅2–46⋅5) versus
36⋅5 (34⋅5–42⋅8);
MCS 47⋅7
(38⋅1–53⋅8) versus
41⋅3 (35⋅6–55⋅8)
Kabata et al.31 – Complications
within
30days
All complications: 8 of 54 versus 17 of
48, P = 0⋅04
CDC grade≥ III: 5 of 54 versus 11 of
48, P<0⋅001
Wound: 1 of 54 versus 7 of 48
Pneumonia: 1 of 54 versus 0 of 48
% weight loss preop.:
median 7⋅4 versus
6⋅3, P n.s.
Kong et al.41 99 (partial) Postop. com-
plications,
CDC
grade≥ II
Complications (CDC grade≥ III): 9 of
65 versus 12 of 62
Wound: 7 of 65 versus 3 of 62
Pulmonary: 6 of 65 versus 4 of 62
LOS: mean(s.d.) 9⋅3(3⋅6) versus
9⋅7(5⋅9) days
% bodyweight change
preop.: −0⋅37
versus−0⋅97,
P = 0⋅173
EORTC-QLQ: no
difference
MacFie et al.32 Weight change
and clinical
outcomes
Weight loss preop.:
P n.s.
Group 1 89⋅3 All complications: 7 of 24 versus 3 of
25
LOS: mean 12 versus 13days
HADS postop.:
anxiety or
depression, P n.s.
Group 2 80⋅7 All complications: 6 of 24 versus 3 of
25
LOS: mean 11 versus 13days
HADS postop.:
anxiety or
depression, P n.s.
Manˇásek et al.53 Complications Wound: 3 of 52 versus 13 of 105 (RR
2⋅2)
LOS: mean(s.d.) 9⋅4(5⋅0) versus
12⋅0(6⋅4) days, P = 0⋅002
% weight loss postop.:
2⋅6 versus 6⋅4, P n.s.
Smedley et al.33 Postop.
change in
bodyweight
Group 1 – All complications: 20 of 41 versus 34
of 44
Buzby definition56: minor 17 of 41
versus 30 of 44; major 3 of 41
versus 4 of 44
LOS: mean(s.d.) 12⋅8(4⋅5) versus
14⋅1(6⋅6) days
– SF-36®: no
difference
Group 2 – All complications: 15 of 32 versus 34
of 44, P<0⋅05
Buzby definition56: minor 10 of 32
versus 30 of 44; major 5 of 32
versus 4 of 44
LOS: mean(s.d.) 11⋅7(5⋅1) versus
14⋅1(6⋅6) days
Only group to gain
weight before
surgery; lost less
weight over course of
study, P = 0⋅05
SF-36®: no
difference
*Comparative data show intervention and control results respectively. SSI, surgical-site infection; CDC, Clavien–Dindo classification; OR, odds ratio;
LOS, length of hospital stay; 6MWT, 6-minute walk test; SF-36®, Short Form 36; PCS, physical component score; MCS, mental component score; n.s.,
not significant; EORTC QLQ, European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire; HADS; Hospital Anxiety
and Depression Scale; RR, relative risk.
© 2020 The Authors. www.bjsopen.com BJS Open
BJS Open published by John Wiley & Sons Ltd on behalf of BJS Society Ltd
Prehabilitation in abdominal cancer surgery
Fig. 5 Forest plot showing the effect of nutrition prehabilitation on overall complications
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studies)9,10,25,36,42–46, multimodal (10 studies)26–29,47–52,
nutrition only (7 studies)30–33,40,41,53, psychological only (2
studies)34,35, CGA with optimization only (4)37,38,54,55 and
smoking cessation only (1 study)39. Sample sizes ranged
from 32 to 443 patients, with most having fewer than 100
patients in each arm; only four studies36,37,54,55 had more
than this, and were mostly non-randomized. The wide
range of sample sizes reflects the diverse primary outcomes
on which power calculations were based, and also the
fact that a small number were pilot or feasibility studies.
Studies were predominantly single-centre, with only eight
studies33,36–38,40,44,45,53 conducted across multiple centres.
Studies were conducted in North America, Europe, Aus-
tralasia, South-East Asia and Brazil. A range of surgical
populations were studied, including colorectal (16 stud-
ies), upper gastrointestinal, hepatobiliary and pancreatic
(9 studies), urological (3 studies), and mixed populations
of gastrointestinal and abdominal malignancies (5 studies)
(Table S1, supporting information).
Twenty-four studies involved patients with cancer exclu-
sively, with a range of 52–78 per cent of patients with
cancer in the remaining studies. Six studies included
patients receiving neoadjuvant therapy. Although the aver-
age age range was 55–81 years, it was less than 70 years
in the majority of studies. Three48,50,52 of the ten multi-
modal studies and four37,38,54,55 of the CGA studies had
populations with an average age over 75 years (Table S1,
supporting information). Nine studies10,37,38,42,48,50,52,54,55
selected patients who were either assessed as frail (using
a recognized frailty screen or criteria) or over a certain
age cut-off; however the method of detecting frailty,
frailty criteria used, and age varied between studies. Two
studies40,41 selected patients who were malnourished, and
one28 selected patients with chronic liver injury (Table S1,
supporting information).
Methodological quality assessment
The assessment of methodological quality is summarized
in Tables 1 and 2. Only three randomized studies blinded
both participants and researchers, one30 by using a placebo
oral nutritional supplement, the second36 by having all
patients attend a preoperative physiotherapy appoint-
ment in which those in the control arm received only an
information booklet whereas patients in the intervention
arm learned breathing exercises, and the third10 by using a
double-informed consent model where control and inter-
vention arms were not aware of each other. The absence of
blinding of either participants or study personnel was the
most common reason for high risk of bias assessment. The
majority of RCTs adequately described randomization, but
allocation concealment was not as reported robustly. Half
of the RCTs adequately described blinding of outcome
assessment10,25,26,29,30,34–36,38–40,42,43. Only two studies27,34
did not adequately report their outcome data (Table 1).
Seven49–55 of the eight non-randomized studies were
graded as moderate risk of bias owing to bias in outcome
measurements and due to confounding factors as they
mainly used historical controls. One study48 was judged
to be at high risk of bias as the authors chose to include a
wider age range in the intervention group than in controls
(Table 2).
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Table 6 Summary of outcomes and results for psychological prehabilitation
Reference Primary study outcome Postoperative outcomes* Functional outcomes* Psychological outcomes*
Chaudhri et al.34 Time to stoma
proficiency, LOS
LOS: 8 versus 10days, P = 0⋅029 HADS postop.: anxiety
33% versus 32%;
depression 17%
versus 24%
Haase et al.35 Systemic analgesic
consumption via
PCA
EORTC-QLQ and GIQLI:
P n.s.
Group 1 Wound infection: 3 of 20 versus 3
of 18
Delirium: 0 of 20 versus 0 of 18
LOS: overall median (range) 12⋅5
(11–14) days
Group 2 Wound infection: 4 of 22 versus 3
of 18
Delirium: 1 of 22 versus 0 of 18
LOS: median (range) 12⋅5
(11–14) days
*Comparative data show intervention and control results respectively. LOS, length of hospital stay; HADS, Hospital Anxiety and Depression Scale;
PCA, patient-controlled analgesia; EORTC QLQ, European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire; GIQLI,
GastroIntestinal Quality of Life Index.
Interventions
Exercise-based interventions
Unimodal exercise interventions were most com-
monly based in hospital and conducted under
supervision36,42,43,45,46; four studies36,42,45,46 included
specific pulmonary exercises or training. Exercise preha-
bilitation programmes varied in intensity from a single
preoperative session36 to one to three times per week, and
ranged from 1 to 6weeks in duration.
Multimodal interventions
Multimodal interventions were more likely to be
home-based26,29,49–51; all included exercise and nutri-
tion, with four26,47,49,52 also including psychological
interventions. The nutritional component of multimodal
interventions commonly involved dietician assessment
and supplementation if required. Two studies28,48 did not
mention supplementation. Two multimodal programmes
specifically mentioned other behavioural modifications:
alcohol reduction49 and smoking cessation50.
Nutrition-based interventions
All nutrition-only prehabilitation studies30–33,40,41,53
included oral nutritional supplementation, but the pre-
scriptions varied from ‘ad libitum’ between meals to
400ml three times a day, with duration varying from 1 to
4weeks. Two studies32,33 included separate intervention
groups that received supplements both before and after
surgery.
Psychology-based interventions
The two psychological prehabilitation studies had differ-
ent interventions; the study by Chaudhri and colleagues34
looked at the impact of a community-based stoma educa-
tion intervention, whereas that by Haase and colleagues35
involved giving patients audio recordings with either
guided imagery or relaxation techniques to listen to before
surgery.
Comprehensive geriatric assessment with optimization
All four CGA prehabilitation studies37,38,54,55 involved
preoperative CGA performed by a geriatrician-led
multidisciplinary team, nutritional optimization and
medication reviews; two studies37,54 included postoper-
ative daily reviews by a geriatric specialist nurse. Two
studies specified that they corrected anaemia with either
blood transfusion55 or supplementation38.
Smoking cessation
One study39 of a smoking cessation intervention met the
inclusion criteria; the intervention involved a single smok-
ing cessation counselling session combined with nicotine
replacement therapy.
Adherence
Adherence was reported in eight9,10,25,36,42–44,46 of the nine
studies of exercise, five26,27,29,47,49 of the ten multimodal
studies, and four30,32,40,41 of the seven nutrition prehabil-
itation studies, with percentages varying from 69 to 100
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Table 7 Summary of outcomes and results for comprehensive geriatric assessment with optimization prehabilitation
Reference
Primary study
outcome Postoperative outcomes* Functional outcomes* Psychological outcomes*
Hempenius et al.37 Postop. delirium Complications (>1): 42 of 127
versus 38 of 133 (OR 1⋅24
(95% c.i. 0⋅73, 2⋅10))
Pulmonary: 31 of 127 versus
27 of 133
Wound: 13 versus 12, P = 0⋅37
Delirium: 12 of 127 versus 19
of 133 (OR 0⋅63 (0⋅29, 1⋅35))
LOS: 8 versus 8days
Independence on
discharge: 76 of 127
versus 87 of 133 (OR
1⋅84 (1⋅01, 3⋅37))
SF-36® bodily pain
same or better: 57 of
127 versus 41 of 133
(OR 0⋅49 (0⋅29,
0⋅82))
Indrakusuma et al.55 30-day mortality,
delirium, LOS
Pneumonia: 37 of 221 versus
31 of 222
Wound: 18 of 221 versus 26 of
222
Delirium: 22 of 221 versus 27
of 222
LOS: 7 (range 5–12) versus 9
(7–14) days; P = 0⋅001
McDonald et al.54 LOS, readmissions
and level of care
at discharge
Complications: mean 0⋅9
versus 1⋅4 (95% c.i. −0⋅13,
−0⋅89), P<0⋅001
Delirium: 52 of 183 versus 8 of
143 (95% c.i. 3⋅06, 14⋅65),
P<0⋅001
Pulmonary: 18 of 183 versus
25 of 143
Wound: 4 of 183 versus 8 of
143
LOS: median 4 versus 6days
(95% c.i. −1⋅06, −4⋅21),
P<0⋅001
Discharge home with
self-care: 114 of 183
versus 73 of 143
(95% c.i. 1⋅02, 2⋅47),
P = 0⋅04
Ommundsen et al.38 Complications,
CDC grade≥ II
Any complication: 40 of 52
versus 55 of 62
CDC grade≥ II: 36 of 52
versus 47 of 62
LOS: 8 versus 8days
Discharged directly
home: 38 of 57
versus 38 of 65,
P = 0⋅2
*Comparative data show intervention and control results respectively. OR, odds ratio; LOS, length of hospital stay; SF-36®, Short Form 36; CDC,
Clavien–Dindo classification.
per cent, 59 to 98 per cent, and 75 to 99 per cent respec-
tively. Adherence was not stated in studies of psychological,
CGA with optimization, or smoking cessation interven-
tions; as these were typically single preoperative interven-
tions, adherence would not have been an issue.
Primary outcome
Twenty different primary outcomes were reported, and 12
of the 33 studies reported more than one primary out-
come measure (Tables 3–8). Four studies25,27,42,44 reported
feasibility as the primary outcome. Postoperative compli-
cations (overall complication rate, severe complications
(Clavien–Dindo grade II or above, or III or above),
pulmonary complications, delirium or site-specific infec-
tion rate) were the most common postoperative outcome
measures, and were reported in all except one study34. LOS
was reported in all except two studies31,46.
Postoperative, functional and psychological
outcomes
Exercise studies
One study10 reported a significant reduction in overall
complications in the intervention arm (20 of 62 versus 38
of 63 in the control arm, P = 0⋅001; relative risk 0⋅5m, 95
per cent c.i. 0⋅3 to 0⋅8). One study9 found a non-significant
higher overall complication rate in the intervention arm
(22 of 56 versus 18 of 54 for the control; P value not
reported), which was attributed to poor compliance in the
intervention group and an increase in physical activity in
the control group. Meta-analysis showed no significant
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Table 8 Summary of outcomes and results for smoking cessation prehabilitation
Reference
Primary study
outcome
Postoperative
outcomes*
Functional
outcomes*
Psychological
outcomes*
Sørensen and Jørgensen39 Postop. wound and
tissue complications
within 30days
Any complication: 11
of 27 versus 13 of 30
Pneumonia: 3 of 27
versus 4 of 30
Wound: 3 of 27 versus
4 of 30
LOS: median (i.q.r.) 11
(10–13) versus 11
(8–14) days
*Comparative data show intervention and control results respectively. LOS, length of hospital stay.
difference in overall complications, but heterogeneity was
high (Fig. 3a).
Two studies reported lower rates of pulmonary compli-
cations in the intervention group: 27 of 218 versus 58 of
214 (adjusted hazard ratio 0⋅48, 95 per cent c.i. 0⋅30 to
0⋅75; P = 0⋅001) in the study by Boden and colleagues36,
and five of 16 versus 11 of 16 (P = 0⋅03) in that of
Soares and co-workers45. Yamana et al.46 also found a lower
Clavien–Dindo grade of pulmonary complication with
intervention (P = 0⋅014). Meta-analysis of five studies (the
study by Boden and colleagues36 was excluded owing to
a significantly different intervention) for pulmonary com-
plications revealed a non-significant trend in favour of the
intervention (Fig. 3b).
A non-significant trend towards lower LOS was also
observed on meta-analysis (Fig. 3c and Table 3).
Two studies25,43 that assessed preoperative change
in CPET variables before and after intervention both
demonstrated significant improvements in peak oxygen
uptake and peak work rate (Table 3). Four studies9,10,44,45
that assessed functional walking ability using the 6MWT
demonstrated no preoperative differences between inter-
vention and control groups. Of the five studies that
reported psychological outcomes, only that by Dunne and
colleagues43 showed an improvement in overall QoL score
measured using the SF-36® (+11, 95 per cent c.i. 1 to 21;
P = 0⋅028) and overall mental health score (+11, 1 to 22;
P = 0⋅037) (Table 3).
Multimodal studies
One study50 found a reduction in overall complications in
the intervention group (17 of 41 versus 26 of 35 in the con-
trol group; P = 0⋅005) (Table 4). Meta-analysis showed a
significant reduction in overall complications after multi-
modal prehabilitation (Fig. 4a). Mazzola and colleagues50
(Clavien–Dindo grade II or above: 7 of 41 versus 15 of
35 respectively, P = 0⋅02) and Souwer and colleagues52
(Clavien–Dindo grade III or above: 14 of 86 versus 24 of
75 respectively; odds ratio (OR) 0⋅4, 95 per cent c.i. 0⋅2 to
0⋅9, P = 0⋅03) both showed a reduction in severe compli-
cations with multimodal prehabilitation. No other studies
demonstrated a reduction in severe complications, delir-
ium, pulmonary or wound infection.
Three studies reported a significant reduction in LOS in
the intervention group: 8⋅4 versus 11 days in the control
group (P = 0⋅029) in the study by Chia and colleagues48;
median LOS 23 (i.q.r. 16–34) versus 30 (21–40) days in
the control group (P = 0⋅045) in the study by Nakajima
and co-workers51; and LOS of 14 days or more in five of
86 versus 17 of 63 patients respectively (OR 0⋅2, 95 per
cent c.i. 0⋅1 to 0⋅5; P = 0⋅001) in the study by Souwer and
colleagues52 (Table 4). Meta-analysis for LOS including six
studies was not significant; however, there were high levels
of heterogeneity (Fig. 4b).
Four multimodal studies26,29,49,51 demonstrated signifi-
cant preoperative improvements in functional walking abil-
ity using the 6MWT after the intervention (mean differ-
ence range 24–62m; all P< 0⋅010) (Table 4). However, in
two of these studies49,51 walking ability was tested only
in the intervention group. No differences in psychologi-
cal outcomes were observed in multimodal studies47,49,59
(Table 4).
Nutrition studies
Two studies reported a reduction in overall complica-
tions in the intervention group: eight of 54 versus 17
of 48 in the control group (P = 0⋅04) in the study by
Kabata and colleagues31, and 15 of 32 versus 34 of 44
respectively (P< 0⋅050) for group 2 in the study by Smedley
et al.33 (Table 5). Meta-analysis demonstrated significantly
fewer overall complications following the intervention
(the historical study of MacFie et al.32 was excluded from
meta-analysis) (Fig. 5).
Kabata and colleagues31 also reported a reduction
in severe complications in the intervention group
(Clavien–Dindo grade III or above: 5 of 54 versus 11
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of 48 in the control group; P< 0⋅001) and Burden and
co-workers40 found a reduction in surgical-site infec-
tion (11 of 55 versus 17 of 45; OR 0⋅41, 95 per cent c.i.
0⋅16 to 1⋅00, P = 0⋅044) (Table 5). Only one study53
reported a reduction in LOS with the intervention
(mean(s.d.) 9⋅4(5⋅0) versus 12⋅0(6⋅4) days in the con-
trol group; P = 0⋅002) (Table 5), with no difference in LOS
on meta-analysis (data not shown).
Burden and colleagues40 (median percentage weight loss
4⋅1 (i.q.r. 1⋅7–7⋅0) in the intervention group versus 6⋅7
(2⋅6–10⋅8) in the control group; P = 0⋅016) and Smedley
et al.33 (less weight loss in group 2, P = 0⋅05) were able to
demonstrate a reduction in preoperative weight loss with
their interventions that was not seen in other studies31,32,41.
No differences in functional walking ability30 or psycho-
logical outcomes30,32,33,41 were found (Table 5).
Psychological studies
Chaudhri and co-workers34 reported a reduction in LOS
in the intervention group (8 versus 10 days in the con-
trol group; P = 0⋅029), which was attributed to fewer
delayed discharges owing to stoma proficiency (Table 6).
Haase et al.35 found no difference in overall complications
between either of their interventions and the control. Nei-
ther psychological intervention had any effect on the mea-
sured psychological outcomes34,35 (Table 6).
Comprehensive geriatric assessment with optimization
McDonald and colleagues54 demonstrated a reduction in
the mean number of complications per patient with the
intervention (0⋅9 versus 1⋅4 in the control group, 95 per
cent c.i. −0⋅13 to −0⋅89; P< 0⋅001), despite a significantly
higher incidence of delirium in the intervention group (52
of 183 versus 8 of 143, 95 per cent c.i. 3⋅06 to 14⋅65;
P< 0⋅001) (Table 7).
Two studies demonstrated a significant reduction in
LOS with intervention: median 4 versus 6 days respec-
tively (95 per cent c.i. −1⋅06 to −4⋅21; P< 0⋅001) in the
study by McDonald et al.54, and a median of 7 (range
5–12) versus 9 (7–14) days respectively (P = 0⋅001) in
that by Indrakusuma and colleagues55. McDonald and
co-workers54 demonstrated an improvement in indepen-
dence on discharge with the intervention (114 of 183 ver-
sus 73 of 143 respectively, 95 per cent c.i. 1⋅02 to 2⋅47;
P = 0⋅04). Hempenius et al.37 observed an improvement in
psychological outcome with intervention (SF-36® bodily
pain scores were the same or better in 57 of 127 versus 41
of 133 in the control group; OR 0⋅49, 95 per cent c.i. 0⋅29
to 0⋅82) (Table 7).
Smoking studies
The smoking cessation trial39 did not find a reduction in
either complications or LOS with intervention (Table 8).
Discussion
This systematic review has found evidence from a num-
ber of trials that exercise, multimodal, nutrition and
CGA with optimization prehabilitation programmes may
reduce the number of postoperative complications after
elective surgery for gastrointestinal and urological can-
cers. It has shown evidence that multimodal, nutritional,
psychological and CGA interventions (but not exercise
interventions or smoking cessation alone) may reduce
LOS. In particular, the small number of studies that
selected high-risk, frail or older patients were more likely
to report improvements in either complications or LOS
compared with studies that included all patients. Equally,
studies conducted in patients undergoing oesophageal and
upper gastrointestinal surgery, known to be associated
with high levels of postoperative morbidity and mortality,
were more likely to demonstrate reductions in pulmonary
complications. However, conclusions are limited by the
methodological quality of included studies, in particular
the lack of blinding of participants in all except three
studies. Significant heterogeneity of interventions also
limits comparison. Adherence to exercise, multimodal
and nutritional interventions was generally high; however,
it is possible that participant selection bias and lack of
blinding may have resulted in more motivated patients
being recruited.
National and international guidelines57–59 recommend
that CGA should be performed in all patients over the
age of 70 years with a diagnosis of cancer to try to predict
treatment toxicity and postoperative complications, and
to aid in shared decision-making. However, there remain
very few studies of CGA in surgical cancer populations,
and the majority of these are limited to its role in risk
prediction and prognostication60,61. This systematic review
identified only two RCTs37,38 evaluating CGA and tailored
interventions. It is worth noting that the median age of
patients in studies included in this review was only 68 years,
with patients in the exercise-alone interventions having a
median age of only 63 years. Only seven of the 33 studies
in this review had a median age greater than 75 years. This
suggests that many prehabilitation studies to date either
failed to recruit older patients due to the location or nature
of the interventions or they excluded older patients owing
to a perceived risk of the interventions, despite mounting
evidence62,63 that exercise-based interventions are safe in
older individuals.
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This review also demonstrated that improvements in pre-
operative functional measures can be made with exercise
prehabilitation (measured by CPET), multimodal inter-
ventions (measured using 6MWT) and nutritional preha-
bilitation (reduction in preoperative weight loss). However,
the link between small statistically significant improve-
ments in these variables and clinical outcomes is not clear.
A number of previous systematic reviews have exam-
ined individual components of prehabilitation in vary-
ing surgical populations: exercise18–20,64,65, exercise in frail
individuals16, multimodal interventions13–15, multimodal
interventions in frail individuals12, nutrition with and with-
out exercise66, and psychological interventions11. All of
these, including the present review, have been limited by
the quality of the underlying evidence. This is the first
review that included all modalities of prehabilitation of rel-
evance to the older adult.
Prehabilitation programmes, regardless of the individual
components they comprise, are complex multicomponent
interventions, and thus should be evaluated as such. The
Medical Research Council in the UK has published a clear
framework for evaluating and conducting trials involving
complex interventions67. Two of the potential reasons for
negative findings in prehabilitation studies are either that
the interventions are too standardized to enable repro-
ducible delivery or that, in efforts to provide truly person-
alized programmes, no two individuals receive the same
intervention. Equally, although there is accumulating evi-
dence that multimodal prehabilitation is likely to be more
beneficial than using a single modality, future trials that use
methodologies designed for evaluating complex interven-
tions will be able to determine which components are most
beneficial for different patients and why.
This review is limited by the heterogeneity of outcomes
reported. LOS and complications were selected as primary
outcomes for this review; however, a number of studies
were powered to detect changes in other primary out-
comes and therefore may have been inadequately powered
for the primary outcomes of this review. The majority of
trials in prehabilitation are relatively small, and this may
contribute towards reporting bias of trials with statisti-
cally significant outcomes. Heterogeneity of studies may
have also contributed to some analyses attaining statisti-
cal significance inappropriately. The wide date range of
included studies may have added to the heterogeneity,
as perioperative care has evolved over the past 20 years
with the introduction of enhanced recovery pathways and
laparoscopic surgery. Another potential limitation is that
diverse surgical procedures with a range of complication
rates have been compared. This may have resulted in
some analyses not reaching significance, and will have
contributed towards heterogeneity on meta-analysis. For
the purpose of this review, a large number of studies were
excluded at full-text review due to lack of reporting of
LOS or complications, which are considered core out-
comes for surgical trials68,69. In particular, a number of
trials of psychological interventions70–75 were excluded
for this reason. Of note, only one preoperative smoking
cessation trial39 and no studies in gynaecological cancer
surgery met the inclusion criteria. The main strength
of this review is the comprehensive nature, whereby all
current prehabilitation modalities in abdominal cancer
surgery were included. This means that the review is of
relevance to a wide range of surgical specialties, identifies
gaps in the current evidence base, and will be of interest to
commissioners looking to fund prehabilitation services.
The reporting of outcomes presented a challenge in this
review owing to the range of outcome measures used;
this reflects complex interventions and the inability to
compare them directly, and raises an important issue for
researchers. The evidence base for prehabilitation might
be stronger if a core outcome set could be used in all tri-
als, irrespective of modality of prehabilitation or surgical
population, to facilitate comparison of interventions. The
StEP-COMPAC group (Standardising Endpoints in Peri-
operative Medicine) have already made progress in this
regard in perioperative medicine76–79. Initiatives such as
the DiSCO (Defining Standards in Colorectal Optimisa-
tion) project led by researchers in the West of Scotland,
which aims to create key sets of standards for prehabilita-
tion in collaboration with patients, their caregivers and the
public, will be vital in ensuring that results are relevant to
service users as well as clinicians, and to the successful pro-
motion of patient-centred care. Future studies also need to
evaluate strategies for implementation and the associated
costs to enable adequate investment at a time of increasing
healthcare costs.
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